Brief: ARCA biopharma Inc Says At Effective Time Of First Merger, Board Is Expected To Consist Of Five Members
03/04/2024 13:50
April 3 (Reuters) - ARCA biopharma Inc ABIO.O :
* ARCA BIOPHARMA INC: AT EFFECTIVE TIME OF FIRST MERGER,
BOARD IS
EXPECTED TO CONSIST OF FIVE MEMBERS
Source text for Eikon: [ID:https://bit.ly/3TMilBw]
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary